Treatment Details - 4.9 months | Surviving Mesothelioma

Treatment Details – 4.9 months

Survival: 4.9 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs: Xeloda
Country: United States
   
City/State/Province: Columbus, Ohio
   
Hospital: Ohio State University Comprehensive Cancer Center
   
Journal: Link
   
Date: 5/2004

Description:
Patients: This Phase II study involved 27 patients with malignant mesothelioma.

Treatment: The treatment consisted of the administration of the chemotherapy drug, capecitabine (xeloda),

Toxicity: One patient died of treatment related diarrhea, dehydration, fever and neutropenia. Other grade 3-4 toxicities included hematologic, hypertension, fatigue, dermatological, anorexia, dehydration, diarrhea, nausea, stomatitis/pharyngitis, infection, and pain.

Results: Median survival was 4.9 months.

Correspondence: Gregory A. Otterson, MD

Get your free copy of
“Surviving Mesothelioma” Today!